ArticleAlimentary pharmacology & therapeutics2022
Worldwide post-marketing safety surveillance experience with tofacitinib in ulcerative colitis.
David T Rubin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
this paperpooled ittrialcites it